155 related articles for article (PubMed ID: 37340510)
1. Metronomic chemotherapy for indolent T-cell lymphoproliferative disorder of the gastrointestinal tract.
Liu H; Cao L; Zhao X; Miao Y; Wu W; Shi X; Zhang X; Yin H; Zhu H; Xu W; Li J; Fan L
Cancer Sci; 2023 Sep; 114(9):3793-3796. PubMed ID: 37340510
[TBL] [Abstract][Full Text] [Related]
2. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
[TBL] [Abstract][Full Text] [Related]
3. VITREORETINAL INVOLVEMENT BY INDOLENT T-CELL LYMPHOPROLIFERATIVE DISORDER OF THE GASTROINTESTINAL TRACT DIAGNOSED BY FLUORESCENCE IN SITU HYBRIDIZATION.
Salman AR; Ferenchak K; Olsen TW; Smith WM; Ketterling RP; McPhail ED; Salomao DR; Dalvin LA
Retin Cases Brief Rep; 2023 Sep; 17(5):572-576. PubMed ID: 37490925
[TBL] [Abstract][Full Text] [Related]
4. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract.
Perry AM; Bailey NG; Bonnett M; Jaffe ES; Chan WC
Int J Surg Pathol; 2019 Feb; 27(1):102-107. PubMed ID: 29986618
[TBL] [Abstract][Full Text] [Related]
5. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
van Vliet C; Spagnolo DV
Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
[TBL] [Abstract][Full Text] [Related]
6. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.
Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M
Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249
[TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological features of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a report of five cases].
Shao SH; Gu HY; Lin DL; Shi HL; Zhang YJ; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):762-766. PubMed ID: 31594039
[No Abstract] [Full Text] [Related]
8. [Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract with the whole wall involvement: report of a case].
Huang WY; Zeng L; Liao SS; Zhang W; Liu FR; Li LX; Huang YH
Zhonghua Bing Li Xue Za Zhi; 2022 Oct; 51(10):1051-1053. PubMed ID: 36207926
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders.
Soderquist CR; Bhagat G
Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873
[TBL] [Abstract][Full Text] [Related]
10. Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a tricky diagnosis of a gastric case.
Zanelli M; Zizzo M; Sanguedolce F; Martino G; Soriano A; Ricci S; Castro Ruiz C; Annessi V; Ascani S
BMC Gastroenterol; 2020 Oct; 20(1):336. PubMed ID: 33054767
[TBL] [Abstract][Full Text] [Related]
11. Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.
Fan W; Niu L; He H; Yuan J; Yuan F; Shi X; Wang Y; Chen M; Huang M; Zhou F; Xu J; Chen Q
Virchows Arch; 2023 Apr; 482(4):729-743. PubMed ID: 36472661
[TBL] [Abstract][Full Text] [Related]
12. Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract.
Hu G; Phillips JL; Dasari S; Jacobs HK; Luchtel RA; Oishi N; Hundal T; Ahmed NH; Satou A; Epstein AL; Bennani NN; Nowakowski GS; Murray JA; Feldman AL
Leukemia; 2020 May; 34(5):1467-1471. PubMed ID: 31836854
[No Abstract] [Full Text] [Related]
13. Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract.
Soderquist CR; Patel N; Murty VV; Betman S; Aggarwal N; Young KH; Xerri L; Leeman-Neill R; Lewis SK; Green PH; Hsiao S; Mansukhani MM; Hsi ED; de Leval L; Alobeid B; Bhagat G
Haematologica; 2020 Jul; 105(7):1895-1906. PubMed ID: 31558678
[TBL] [Abstract][Full Text] [Related]
14. Oral manifestation of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: A potential diagnostic pitfall.
Saggini A; Baciorri F; Di Prete M; Zizzari AG; Anemona L
J Cutan Pathol; 2020 May; 47(5):494-496. PubMed ID: 32003865
[No Abstract] [Full Text] [Related]
15. Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and Outcomes.
Masciopinto P; Bellitti E; Arcuti E; Battisti O; Cazzato G; Perrone T; Longo MC; Laddaga FE; Maiorano E; Musto P; Ingravallo G; Gaudio F
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e745-e750. PubMed ID: 35501257
[TBL] [Abstract][Full Text] [Related]
16. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
Wang X; Ng CS; Chen C; Yu G; Yin W
Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
[TBL] [Abstract][Full Text] [Related]
17. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract in a renal transplant patient: diagnostic pitfalls and clinical challenges.
Soon G; Wang S
Pathology; 2017 Aug; 49(5):547-550. PubMed ID: 28673428
[No Abstract] [Full Text] [Related]
18. Diagnostic approach to T- and NK-cell lymphoproliferative disorders in the gastrointestinal tract.
Susan SH; Ng SB; Wang S; Tan SY
Semin Diagn Pathol; 2021 Jul; 38(4):21-30. PubMed ID: 34016481
[TBL] [Abstract][Full Text] [Related]
19. Indolent NK-cell lymphoproliferative disorder of the GI tract: a rare indolent neoplasm of the GI tract.
Attieh M; Asakrah S
Blood; 2023 Apr; 141(16):2033. PubMed ID: 37079328
[No Abstract] [Full Text] [Related]
20. Lymphomas and Amyloid in the Gastrointestinal Tract.
Ware AD; Wake LM; Fedoriw Y
Surg Pathol Clin; 2023 Dec; 16(4):719-743. PubMed ID: 37863562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]